the work, described honestly.
Pharmaceutical engagements involve licence positions, audit findings and formulations that clients reasonably do not want published. We write up a case study only where the client has agreed to it, and we do not publish invented or composite examples to fill the gap.
no published case studies yet.
Client-consented write-ups will appear here as they are cleared for publication. If you would like to discuss comparable work before then, ask us directly — we can talk through relevant experience in a conversation even where we cannot publish it.
Ask about relevant work →how we document an engagement.
Every engagement is documented to the same structure, whether or not it is ever published.
Starting position
What was actually in place — licences held, systems running, the finding or decision that prompted the work.
Scope
What we were asked to do, what we deliberately left out, and the constraints we worked inside.
Work done
The assessment, the documentation produced, and the specific changes made — at a level of detail you could act on.
Outcome and limits
What changed, what did not, and what remained open at handover. Including the parts that did not go to plan.
where engagements typically sit.
These are our practice areas, not claims about specific projects.
Regulatory Compliance
Licensing, CDSCO and state drug authority requirements, and documentation that holds up under inspection.
Manufacturing Optimization
Yield, changeover, capacity and cost — finding where a line actually loses time and money.
Quality Assurance
GMP systems, deviation and CAPA handling, and the quality practice that keeps them working.
Product Development
Taking a formulation from concept to a manufacturable, stable, documented product.
Business Strategy
Portfolio, pricing, sourcing and go-to-market decisions for pharmaceutical businesses.